![John McHutchison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John McHutchison
Director/Board Member at
ASSEMBLY BIOSCIENCES, INC.
Net worth: 507 506 $ as of 31/05/2026
Profile
John G.
McHutchison is the founder of Actio Biosciences, Inc., founded in 2021, serving as Director.
Current jobs include Chairman & Chief Executive Officer at Tune Therapeutics, Inc. starting 2025, Director at Assembly Biosciences, Inc. since 2019, Director at Evox Therapeutics Ltd. since 2021, and Member at The Royal Australasian College of Physicians.
Former jobs include President & Chief Executive Officer at Velia, Inc. from 2023 to 2025, Director at Oxford BioTherapeutics Ltd. from 2017 to 2023, Associate Director at Duke Clinical Research Institute, Medical Director-Liver Transplantation at Scripps Clinic & Research Foundation, Independent Director at Metacrine, Inc. from 2020 to 2023, Chief Scientific Officer, Head-R&D at Gilead Sciences, Inc. from 2018 to 2019, Assistant Professor at the University of Southern California, and Professor at Duke University Medical Center.
Education includes undergraduate and doctorate degrees from the University of Melbourne.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/06/2026 | 18,348 ( 0.12% ) | 507 506 $ | 31/05/2026 |
John McHutchison active positions
| Companies | Position | Start |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Director/Board Member | 06/08/2019 |
The Royal Australasian College of Physicians
 The Royal Australasian College of Physicians The non-profit company is based in Sydney, Australia. The Royal Australasian College of Physicians (RACP) is a professional organization representing over 30,000 medical specialists and trainees across 33 specialties in Australia and Aotearoa. It provides education and training pathways for physicians and paediatricians, including basic and advanced training, examinations, accreditation of training sites, and continuing professional development. The college supports diverse training environments through programs such as the Specialist Training Program, which promotes rural, private, and indigenous health service placements. RACP emphasizes indigenous health equity and cultural safety, advocates for healthcare policy, ethics, diversity, and gender equity, and engages members through committees and special interest groups. The organization invests in modernizing its infrastructure with initiatives like a new training management platform and a member relationship management system. It offers wellbeing resources, including a confidential 24/7 support program for counseling and coaching. Through the RACP Foundation, the college advances medical research and education by awarding fellowships, scholarships, grants, and prizes to support career development, research projects, and professional growth. The foundation and college also conduct educational research and evaluation to improve training quality and healthcare outcomes. The Royal Australasian College of Physicians was founded in 1938. | Corporate Officer/Principal | - |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Director/Board Member | 18/01/2021 |
Tune Therapeutics, Inc.
 Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Chief Executive Officer | 01/03/2025 |
Actio Biosciences, Inc.
 Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for rare diseases | Founder | 01/10/2021 |
Former positions of John McHutchison
| Companies | Position | End |
|---|---|---|
Velia, Inc.
 Velia, Inc. Packaged SoftwareTechnology Services Provides software development services | Chief Executive Officer | 01/03/2025 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Director/Board Member | 24/04/2023 |
| METACRINE, INC. | Director/Board Member | 23/03/2023 |
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 02/08/2019 |
| ░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of John McHutchison
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke Clinical Research Institute
 Duke Clinical Research Institute Pharmaceuticals: OtherHealth Technology Manufactures medical and botanical products | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scripps Clinic & Research Foundation | |
The Royal Australasian College of Physicians
The Royal Australasian College of Physicians The non-profit company is based in Sydney, Australia. The Royal Australasian College of Physicians (RACP) is a professional organization representing over 30,000 medical specialists and trainees across 33 specialties in Australia and Aotearoa. It provides education and training pathways for physicians and paediatricians, including basic and advanced training, examinations, accreditation of training sites, and continuing professional development. The college supports diverse training environments through programs such as the Specialist Training Program, which promotes rural, private, and indigenous health service placements. RACP emphasizes indigenous health equity and cultural safety, advocates for healthcare policy, ethics, diversity, and gender equity, and engages members through committees and special interest groups. The organization invests in modernizing its infrastructure with initiatives like a new training management platform and a member relationship management system. It offers wellbeing resources, including a confidential 24/7 support program for counseling and coaching. Through the RACP Foundation, the college advances medical research and education by awarding fellowships, scholarships, grants, and prizes to support career development, research projects, and professional growth. The foundation and college also conduct educational research and evaluation to improve training quality and healthcare outcomes. The Royal Australasian College of Physicians was founded in 1938. | |
Assembly Biosciences, Inc.
 Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Health Technology |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Health Technology |
Velia, Inc.
Velia, Inc. Packaged SoftwareTechnology Services Provides software development services | Technology Services |
Actio Biosciences, Inc.
Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for rare diseases | Health Technology |
- Stock Market
- Insiders
- John McHutchison
